Beskrivning
Land | Norge |
---|---|
Lista | Oslo Bors |
Sektor | Handel & varor |
Industri | Dagligvaror |
2020-11-03 14:22:37
Fornebu - November 3, 2020 Ola Snøve, Chairman of Aker BioMarine AS, purchased in the period from 30 October to 3 November 185 000 shares in Aker BioMarine AS at an average price of NOK 81,9 per share through his wholly owned company Storbrea AS. The shares were acquired on Merkur Market. Following the transaction, Snøve holds a total of 185 000 shares in Aker BioMarine AS. Katrine Klaveness, Chief Financial Officer, purchased on 3 November 4 450 shares in Aker BioMarine AS at an average price of NOK 83 per share. The shares were acquired on Merkur Market. Following the transaction, Klaveness holds a total of 4 450 shares in Aker BioMarine AS. Sigve Nordrum, EVP Animal Health and Nutrition, purchased on 30 October 4 600 shares in Aker BioMarine AS at an average price of NOK 80,90 per share. The shares were acquired on Merkur Market. Following the transaction, Nordrum holds a total of 5 600 shares in Aker BioMarine AS. Shauna Mcneill, EVP Innovation, purchased on 30 October 4 870 shares in Aker BioMarine AS at an average price of NOK 81,95 per share. The shares were acquired on Merkur Market. Following the transaction, Mcneill holds a total of 4 870 shares in Aker BioMarine AS. Tim de Haas, EVP Human Health and Nutrition, purchased on 30 October 4 650 shares in Aker BioMarine AS at an average price of NOK 81,95 per share. The shares were acquired on Merkur Market. Following the transaction, de Haas holds a total of 4 650 shares in Aker BioMarine AS. Tone Lorentzen, EVP Supply Chain, purchased on 2 November 4 500 shares in Aker BioMarine AS at an average price of NOK 83,80 per share. The shares were acquired on Merkur Market. Following the transaction, Lorentzen holds a total of 4 500 shares in Aker BioMarine AS. For further information, please contact: Katrine Klaveness, CFO Phone: +47 991 58 915 About Aker BioMarine: Aker BioMarine is a biotech innovator and Antarctic krill-harvesting company, developing krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. The company’s fully transparent value chain stretches from sustainable krill harvesting in pristine Antarctic waters through its Montevideo logistics hub, Houston production plant, and all the way to customers around the world. The company is dedicated to improving human and planetary health.